The partners of the Company include BECTON DICKINSON International the branch of Becton Dickinson B.V. Belgium which is an international manufacturer of medical equipment and medical products, whose principal business is the improvement of drug delivery systems and diagnostics of infectious and oncological diseases and support in the development of new medicines. BD develops, manufactures and sells medical devices, laboratory consumables, antibodies, reagents and diagnostic products through the Company's three main business units: BD Medical Systems, BD Diagnostic Systems, BD Biotechnology.

One of the main products of BEKTON DICKINSON International Manufacturer is a bacteriological analyzer BD Bactec™ MGIT™ 960. This is an automated modular system (3 sections) for Crop Testing & Control System intended for invitro mycobacteria diagnostics from clinical specimens: moisture, bronchial washings, pleural exudate, synovial and cerebral fluids and determine the sensitivity of mycobacteria to first-line drugs (streptomycin, isoniazid, rifampicin, ethambutol and pyrazinamide).

Furthermore, the Smears Preparing & Staining System for BD PrepStain™ Cytological Studies proved its demand in the market of medical equipment in Kazakhstan. The technological feature of this system is that the material under study is taken into a special preservation solution, which ensures its safety without destruction and loss of cells. At the same time, all cellular material is preserved, the cells do not change their morphological and immunocytochemical properties.

A very important advantage of BD PrepStain Reagents is the possibility of their use for molecular biological studies, such as the immunocytochemical detection of microorganisms in cervical smears. Immunocytochemical method allows to detect human papillomavirus in thin-layer specimen whose identification is of great importance in anti-cancer screening.

BD PrepStain is a universal system that can be used both for the preparation of cytological specimen in gynecology and for the study of other biological material.

As noted above, LifeMed Holding LLP takes part in the State Screening Program for the early detection of cancer pathologies (Cervical Cancer) of the women reproductive system by supplying the Cell Cyan 100A liquid cytology apparatus to medical organizations of our country.

Papanicolaou test for cervical cancer is a simple way to screen cancer cells with a macroscopic examination of the cervix. However, the accuracy of the results can be problematic, depending on the sampling method, location and reading ability, while the false negative result rate, which shows a negative result even in the presence of the disease is about 10-30%.

Liquid Cytology Test (Cell Scan100A) of LifeMed Holding is a test that complements the shortcomings of traditional cytology by creating a single-layer pallet that evenly distributes cells from the cervix. This reduces the field of view of the microscope, reduces errors in the reading process and makes it possible to get accurate readings with 100% efficiency without cytopathic changes. The Sell Scan 100A device allows you to see all the cells of a biological material, because they are evenly distributed on the pallet, and foreign materials are also removed by the device.

Today, the nutrient medium M-Kit, a product of the Tuberculosis Institute at the Korean Tuberculosis Association, South Korea, provides significant assistance in the specific diagnosis of tuberculosis and determination of the sensitivity of mucobacteria of tuberculosis to fist-line and second-line drugs.

At the beginning of 2019, the Company signed an Agreement with a well-known manufacturer of medical equipment in the field of ELISA, PCR diagnostics by FUJIREBIO EUROPE N.V. Corporation, which has more than 50 years of experience in developing IVD Testing Solutions.

The corporation is the world leader in the field of high-quality tests for Invitro Diagnosis (IVD). Historically originated in Japan with a deep-rooted culture of country excellence, Fujirebio over the years has been shaped by the successful integration of innovative and experienced international IVD players such as CentocorDiagnostics in 1998, CanAgDiagnostics in 2006, and Innogenetics in 2010. The Corporation’s global presence includes offices in the USA, Europe, Latin America and Asia, as well as it has an extensive international distribution network.

In addition to operational activities, the company provides sponsorship support to medical workers of our country to increase their professional training, as well as mastering modern methods of diagnosing and treating diseases both in Kazakhstan and in neighboring countries, especially in medical universities, medical clinics in concert with the manufacturers from the USA, South Korea, Belgium, Germany, France, India, Turkey, the Russian Federation.

The Company pays great attention to rendering charitable assistance. In particular, assistance was provided to KULYNSHAK Children's Charity Foundation, students from large families and children with disabilities.